glutamicum were shown to contribute to the low p K a value of the active site cysteine 37,38
Amgen, another key player in related therapeutic areas, trades at a P/E of roughly 25.9-26.7x
Reported changes involved communication, attention, cognitive function, and hyperactivity or aggression
What happens to weight loss if the dose is reduced
Key points to consider when interpreting the evidence: Most studies are short-term , typically lasting fewer than 12 weeks, making it difficult to assess long-term efficacy or safety Results appear more pronounced in older adults or individuals with obesity, compared to younger, healthy populations L-carnitine alone, without dietary or lifestyle changes , is unlikely to produce clinically meaningful weight loss Neither NICE nor the NHS recommends L-carnitine supplementation as part of any weight management pathway
Powder forms circulating outside of regulated clinical trials are typically sold as 'research chemicals' and have not undergone the rigorous quality, safety, and stability testing required for medicines approved by the MHRA
